Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP508948.RAfxqwp8YaMl4MvjwqtmW5s9Eozyqs1cukeSW6YPr8b9s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP508948.RAfxqwp8YaMl4MvjwqtmW5s9Eozyqs1cukeSW6YPr8b9s130_assertion type Assertion NP508948.RAfxqwp8YaMl4MvjwqtmW5s9Eozyqs1cukeSW6YPr8b9s130_head.
- NP508948.RAfxqwp8YaMl4MvjwqtmW5s9Eozyqs1cukeSW6YPr8b9s130_assertion description "[We screened for the most common LRRK 2 mutation in a series of patients with Parkinson's Disease, Alzheimer's disease, Progressive Supranuclear Palsy, Multiple System Atrophy and frontotemporal dementia, as well as in neurologically normal controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP508948.RAfxqwp8YaMl4MvjwqtmW5s9Eozyqs1cukeSW6YPr8b9s130_provenance.
- NP508948.RAfxqwp8YaMl4MvjwqtmW5s9Eozyqs1cukeSW6YPr8b9s130_assertion evidence source_evidence_literature NP508948.RAfxqwp8YaMl4MvjwqtmW5s9Eozyqs1cukeSW6YPr8b9s130_provenance.
- NP508948.RAfxqwp8YaMl4MvjwqtmW5s9Eozyqs1cukeSW6YPr8b9s130_assertion SIO_000772 16102903 NP508948.RAfxqwp8YaMl4MvjwqtmW5s9Eozyqs1cukeSW6YPr8b9s130_provenance.
- NP508948.RAfxqwp8YaMl4MvjwqtmW5s9Eozyqs1cukeSW6YPr8b9s130_assertion wasDerivedFrom befree-2016 NP508948.RAfxqwp8YaMl4MvjwqtmW5s9Eozyqs1cukeSW6YPr8b9s130_provenance.
- NP508948.RAfxqwp8YaMl4MvjwqtmW5s9Eozyqs1cukeSW6YPr8b9s130_assertion wasGeneratedBy ECO_0000203 NP508948.RAfxqwp8YaMl4MvjwqtmW5s9Eozyqs1cukeSW6YPr8b9s130_provenance.